Celator Pharmaceuticals Inc (NASDAQ:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, announced the pricing of an underwritten public offering …
Celator Pharmaceuticals Inc (NASDAQ:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced that it intends to offer and …
Analysts from Robert W. Baird and Roth Capital explain why they are bullish on rival drug-maker Sarepta Therapeutics Inc (NASDAQ:SRPT) and biopharmaceutical firm Celator Pharmaceuticals …
Celator Pharmaceuticals Inc (NASDAQ:CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, …
Roth Capital analysts weighed in on cancer treatments maker Celator Pharmaceuticals Inc (NASDAQ:CPXX) and cannabis-based drug maker GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), after both released …
Linn Energy LLC (NASDAQ:LINE) is falling 29% in pre-market trading after the company posted disappointing Q4:15 revenues earlier this morning. The company reported …
Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced positive results from the Phase 3 trial of VYXEOS™ (cytarabine: daunorubicin) Liposome for Injection (also known as CPX-351) in …
Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced that it was given a notice of allowance of claims by the United States Patent and Trademark Office for …
Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced that the company has been approved to sell$1,802,000 of its net operating losses and unused research and development (R&D) …
Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced the presentation of positive results from its CombiPlex® technology platform applied to drug combinations incorporating molecularly targeted agents (MTAs) …
